Induced menopause in women with endometriosis
A new tool for clinicians, Induced menopause in women with endometriosis, is now available on the BMS website.
HRT preparations and equivalent alternatives
The BMS has produced a document in response to the ongoing HRT shortages and to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
The RCOG is recruiting a new remunerated honorary Women’s Voices Lead
Are you passionate about women’s health advocacy? Could you lead the broad range of lay voices that support the Royal College of Obstetricians and Gynaecologists’ work to improve women’s health?
Response from the MHRA /FOI
Further to our letter sent on 9 September to Dr June Raine, Interim CEO of the MHRA and to the questions we asked under the Freedom of Information Act, responses have now been received (PDF, 172KB). The medical advisory council of the BMS has reviewed these responses and the following letter was sent to Dr [...]
10th Anniversary of World Menopause Day
Today, Friday 18 October, is World Menopause Day, established in 2009 by the International Menopause Society.
The BMS launches video series: The Menopause Explained
To coincide with World Menopause Day, 18 October, the British Menopause Society has launched a series of seven short videos covering different aspects of the menopause.
BMJ Editorial: HRT and breast cancer risk: we must prevent another setback in women’s health
Review of the data published in the Lancet last Friday, 11 October 2019.
BMS Response to the Government’s new measures to tackle HRT shortages
The British Menopause Society welcomes the Government’s new measures that restrict exporting hormone replacement therapy (HRT) outside the UK.
British Menopause Society further update on HRT supply shortages (23rd September 2019)
The British Menopause Society has produced this further update on the current availability of HRT products in response to the ongoing HRT shortages. The objective of this is to provide guidance to BMS members and clinical practitioners who may be experiencing difficulties with HRT supplies.
BMS response to MHRA recommendations
The medical advisory council of the BMS has reviewed the recommendations issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) on 30 August. The following letter was sent to Dr June Raine, interim CEO of the MHRA.